Your session is about to expire
← Back to Search
Outreach Interventions for Ovarian Cancer
N/A
Waitlist Available
Led By Colleen McBride, PhD
Research Sponsored by Emory University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Survivors must be diagnosed with ovarian, fallopian tube, or peritoneal cancers
Survivors must not be deceased per the registry's records
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 31 months
Awards & highlights
Study Summary
This trial tests an intervention to get ovarian cancer survivors and their at-risk relatives to consider cancer genetic services. It includes foot-in-the-door techniques, tailored/targeted print, website support, and short messages.
Who is the study for?
This trial is for ovarian cancer survivors listed in the Georgia Cancer Registry and their close relatives who are at least 25 years old, can access the internet, read English, and are not incarcerated. Survivors must have been diagnosed with ovarian-related cancers in Georgia and still be living.Check my eligibility
What is being tested?
The study tests a message-based communication outreach to encourage ovarian cancer survivors and their relatives to consider genetic services. It uses tailored messages, website support, and foot-in-the-door techniques aimed at increasing awareness of prevention strategies.See study design
What are the potential side effects?
Since this intervention involves informational outreach rather than medical treatment, there are no direct physical side effects. Participants may experience emotional or psychological impacts from discussing sensitive health information.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
Participants must have been diagnosed with ovarian, fallopian tube, or peritoneal cancers.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ up to 31 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 31 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Proportion of Relatives Completing Telegenetic Counseling
Proportion of Relatives of Survivors Accessing the Website
Proportion of Survivors Accessing the Website
+1 moreSecondary outcome measures
Number of Pages Viewed by Relatives
Number of Pages Viewed by Survivors
Number of Return Visits to Website by Relatives
+4 moreTrial Design
4Treatment groups
Experimental Treatment
Active Control
Group I: Message-based Outreach Intervention for Close RelativesExperimental Treatment1 Intervention
Close relatives of cancer survivors who were randomized to receive the message-based outreach. Close relatives will have access to the expanded version of the study website and free genetic counseling.
Group II: Message-based Outreach Intervention (MBI) for SurvivorsExperimental Treatment1 Intervention
Cancer survivors randomized to receive a targeted letter with a unique website log in, access to the expanded website, free genetic counseling, and short message service (SMS) reminders.
Group III: Standard Outreach for Close RelativesActive Control1 Intervention
Close relatives of cancer survivors who were randomized to receive the standard outreach. Close relatives will have access to a condensed version of the study website and free genetic counseling.
Group IV: Standard Outreach for SurvivorsActive Control1 Intervention
Cancer survivors randomized to receive the standard outreach consisting of a standard letter with website access, access to a condensed version of the study website, and free genetic counseling.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Message-based Outreach Intervention for Survivors
2021
N/A
~350
Message-based Outreach Intervention for Close Relatives
2021
N/A
~350
Find a Location
Who is running the clinical trial?
Emory UniversityLead Sponsor
1,636 Previous Clinical Trials
2,560,224 Total Patients Enrolled
2 Trials studying Ovarian Cancer
71 Patients Enrolled for Ovarian Cancer
National Cancer Institute (NCI)NIH
13,657 Previous Clinical Trials
40,933,318 Total Patients Enrolled
285 Trials studying Ovarian Cancer
73,417 Patients Enrolled for Ovarian Cancer
Colleen McBride, PhDPrincipal InvestigatorEmory University
Media Library
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are there any patient recruitment opportunities with this research endeavor?
"Indubitably, clinicaltrials.gov attests that this experiment is presently searching for participants. This project was initially posted on 24th July 2021 and had its latest update on 18th October 2022. 1 trial site must find 1240 patients to fill the study's quota."
Answered by AI
What is the cap on participants in this research?
"Affirmative. Clinicaltrials.gov declares that this medical experiment, which was published on July 24th 2021, is actively enrolling patients. A total of 1240 individuals are necessary for recruitment from 1 location."
Answered by AI
What results can be expected from this medical experiment?
"This medical trial will last a maximum of 31 months and seeks to measure the proportion of survivors completing telegenic counselling as its primary outcome. As secondary metrics, researchers are looking at number of return visits to the website by both survivors and relatives; in addition, they plan on measuring duration (in minutes) that survivors spend on said website."
Answered by AI
Popular Categories
Share this study with friends
Copy Link
Messenger